150 related articles for article (PubMed ID: 27453702)
1. Tobramycin and Beta-Lactam Antibiotic Use in Cystic Fibrosis Exacerbations: A Pharmacist Approach.
Zobell JT; Epps K; Kittell F; Sema C; McDade EJ; Peters SJ; Duval MA; Pettit RS
J Pediatr Pharmacol Ther; 2016; 21(3):239-46. PubMed ID: 27453702
[TBL] [Abstract][Full Text] [Related]
2. National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations.
Prescott WA
J Pediatr Pharmacol Ther; 2011 Oct; 16(4):262-9. PubMed ID: 22768010
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey.
Pettit RS; Peters SJ; McDade EJ; Kreilein K; Patel R; Epps K; Kittell F; Duval MA; Zobell JT
J Pediatr Pharmacol Ther; 2017; 22(6):406-411. PubMed ID: 29290740
[TBL] [Abstract][Full Text] [Related]
4. Continuous-infusion antipseudomonal Beta-lactam therapy in patients with cystic fibrosis.
Prescott WA; Gentile AE; Nagel JL; Pettit RS
P T; 2011 Nov; 36(11):723-63. PubMed ID: 22346306
[TBL] [Abstract][Full Text] [Related]
5. A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients.
Zobell JT; Young DC; Waters CD; Ampofo K; Cash J; Marshall BC; Olson J; Chatfield BA
Pediatr Pulmonol; 2011 Oct; 46(10):987-90. PubMed ID: 21520438
[TBL] [Abstract][Full Text] [Related]
6. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Prescott WA
Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
[TBL] [Abstract][Full Text] [Related]
7. High-Dose, Extended-Interval Gentamicin and Tobramycin for Pediatric Inpatients: A Survey of Canadian Hospital Pharmacists.
Roy C; Gray C; Ruda L; Bell A; Bolt J
Can J Hosp Pharm; 2016; 69(5):367-375. PubMed ID: 27826154
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.
Hong LT; Liou TG; Deka R; King JB; Stevens V; Young DC
Chest; 2018 Nov; 154(5):1108-1114. PubMed ID: 29908155
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the Impact of Education on Pharmacist Tobramycin Dose Recommendations for Cystic Fibrosis and a Review of Perceptions on Pharmacist-Led Charting.
Le T; Lord L; Pignataro S; Simioni D; Cheah R
J Pharm Pract; 2022 Dec; 35(6):903-910. PubMed ID: 34013814
[TBL] [Abstract][Full Text] [Related]
10. Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.
Higgins KL; Noda C; Stultz JS
J Pediatr Pharmacol Ther; 2018; 23(2):159-163. PubMed ID: 29720919
[TBL] [Abstract][Full Text] [Related]
11. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary.
Hong LT; Downes KJ; FakhriRavari A; Abdul-Mutakabbir JC; Kuti JL; Jorgensen S; Young DC; Alshaer MH; Bassetti M; Bonomo RA; Gilchrist M; Jang SM; Lodise T; Roberts JA; Tängdén T; Zuppa A; Scheetz MH
Pharmacotherapy; 2023 Aug; 43(8):736-739. PubMed ID: 37615244
[TBL] [Abstract][Full Text] [Related]
12. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists.
Hong LT; Downes KJ; FakhriRavari A; Abdul-Mutakabbir JC; Kuti JL; Jorgensen S; Young DC; Alshaer MH; Bassetti M; Bonomo RA; Gilchrist M; Jang SM; Lodise T; Roberts JA; Tängdén T; Zuppa A; Scheetz MH
Pharmacotherapy; 2023 Aug; 43(8):740-777. PubMed ID: 37615245
[TBL] [Abstract][Full Text] [Related]
13. Review of Tobramycin Dosing in Pediatric Patients With Cystic Fibrosis.
Imburgia TA; Seagren RM; Christensen H; Lasarev MR; Bogenschutz MC
J Pediatr Pharmacol Ther; 2023; 28(1):63-70. PubMed ID: 36777977
[TBL] [Abstract][Full Text] [Related]
14. A survey of once-daily dosage tobramycin therapy in patients with cystic fibrosis.
Van Meter DJ; Corriveau M; Ahern JW; Lahiri T
Pediatr Pulmonol; 2009 Apr; 44(4):325-9. PubMed ID: 19330772
[TBL] [Abstract][Full Text] [Related]
15. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Zobell JT; Epps KL; Young DC; Montague M; Olson J; Ampofo K; Chin MJ; Marshall BC; Dasenbrook E
Pediatr Pulmonol; 2015 Jun; 50(6):552-9. PubMed ID: 25559432
[TBL] [Abstract][Full Text] [Related]
16. New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis.
Koloskoff K; Thirion DJG; Matouk E; Marsot A
Ther Drug Monit; 2023 Apr; 45(2):251-258. PubMed ID: 36070759
[TBL] [Abstract][Full Text] [Related]
17. Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis.
Deschamp AR; Pettit RS; Donaldson JA; Slaven JE; Davis SD
SAGE Open Med; 2017; 5():2050312117736694. PubMed ID: 29085640
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum concentrations achieved with an empiric once-daily tobramycin dosage regimen in children and adults with cystic fibrosis.
Vandenbussche HL; Homnick DN
J Pediatr Pharmacol Ther; 2012 Jan; 17(1):67-77. PubMed ID: 23118659
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic analysis of weight- and height-scaled tobramycin dosage regimens for patients with cystic fibrosis.
Alghanem SS; Touw DJ; Thomson AH
J Antimicrob Chemother; 2019 Aug; 74(8):2311-2317. PubMed ID: 31322695
[TBL] [Abstract][Full Text] [Related]
20. A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers.
Grube PM; Autry EB; Kormelink LN; Young DC; Zobell JT; Bhakta ZN; Schadler AD; Kuhn RJ
Pediatr Pulmonol; 2024 Mar; 59(3):652-661. PubMed ID: 38050809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
